ANI Pharmaceuticals, Inc.

Estimated for Congress, as filed for insiders · by filing month · past 24 months

SC Stephen P. Carey SVP & CFO 10 filings · 0 buys, 10 sales NL Nikhil Lalwani PRESIDENT & CEO 6 filings · 0 buys, 6 sales CM Christopher Mutz HEAD OF RARE DISEASE 6 filings · 0 buys, 6 sales KD Krista Davis SVP, CHIEF HR OFFICER 5 filings · 0 buys, 5 sales OG Ori Gutwerg SVP, GENERICS 5 filings · 0 buys, 5 sales PW Patrick D Walsh Director 4 filings · 0 buys, 4 sales CG Chad Gassert SVP - CORP. DEV. & STRATEGY 2 filings · 0 buys, 2 sales TH Thomas Haughey Director 2 filings · 0 buys, 2 sales

All 14 filers

ML Matthew J Leonard Director 2 filings · 0 buys, 2 sales AP Antonio R Pera Director 2 filings · 0 buys, 2 sales TR Thomas Andrew Rowland SVP, HEAD - ESTABLISHED BRANDS 2 filings · 0 buys, 2 sales MS Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS 2 filings · 0 buys, 2 sales RT Renee P Tannenbaum Director 1 filing · 0 buys, 1 sale JT Jeanne Thoma Director 1 filing · 0 buys, 1 sale

Stephen P. CareySALE SVP & CFO $208K
2,850 sh × $72.87
Exec Oct 29
Filed Oct 30 · 4:36 PM ET Nikhil LalwaniSALE PRESIDENT & CEO $388K
5,400 sh × $71.89
Exec Oct 15
Filed Oct 16 · 6:50 PM ET Stephen P. CareySALE SVP & CFO $208K
2,850 sh × $73.00
Exec Sep 29
Filed Sep 30 · 4:52 PM ET Nikhil LalwaniSALE PRESIDENT & CEO $383K
5,400 sh × $71.00
Exec Sep 15
Filed Sep 16 · 4:20 PM ET Stephen P. CareySALE SVP & CFO $207K
2,850 sh × $72.80
Exec Aug 31
Filed Sep 1 · 6:18 PM ET Nikhil LalwaniSALE PRESIDENT & CEO $401K
5,400 sh × $74.30
Exec Aug 25
Filed Aug 26 · 6:15 PM ET Ori GutwergSALE SVP, GENERICS $243K
3,162 sh × $77.00
Exec Aug 10
Filed Aug 11 · 8:57 PM ET Stephen P. CareySALE SVP & CFO $232K
2,850 sh × $81.36
Exec Jul 29
Filed Jul 30 · 4:02 PM ET Stephen P. CareySALE SVP & CFO $285K
3,313 sh × $86.00
Exec Jul 2
Filed Jul 6 · 9:40 PM ET Stephen P. CareySALE SVP & CFO $240K
2,850 sh × $84.12
Exec Jun 29
Filed Jun 30 · 5:30 PM ET Thomas HaugheySALE Director $162K
2,000 sh × $80.88
Exec Jun 8
Filed Jun 10 · 5:30 PM ET Stephen P. CareySALE SVP & CFO $265K
3,312 sh × $80.00
Exec Jun 5
Filed Jun 9 · 5:30 PM ET Ori GutwergSALE SVP, GENERICS $220K
2,772 sh × $79.50
Exec May 12
Filed May 13 · 5:30 PM ET Nikhil LalwaniSALE PRESIDENT & CEO $4.3M
55,000 sh × $77.57
Exec May 11
Filed May 13 · 5:30 PM ET Patrick D WalshSALE Director $1.1M
13,973 sh across 2 lots
Exec May 11
Filed May 13 · 5:30 PM ET Christopher MutzSALE HEAD OF RARE DISEASE $227K
3,162 sh × $71.64
Exec Mar 13
Filed Mar 13 · 5:30 PM ET Thomas Andrew RowlandSALE SVP, HEAD - ESTABLISHED BRANDS $357K
4,772 sh × $74.91
Exec Mar 11
Filed Mar 13 · 5:30 PM ET Krista DavisSALE SVP, CHIEF HR OFFICER $488K
6,572 sh across 2 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET Christopher MutzSALE HEAD OF RARE DISEASE $425K
5,723 sh across 2 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET Stephen P. CareySALE SVP & CFO $552K
7,312 sh across 2 lots
Exec Mar 5
Filed Mar 5 · 5:30 PM ET Ori GutwergSALE SVP, GENERICS $158K
2,060 sh × $76.50
Exec Mar 3
Filed Mar 4 · 5:30 PM ET Patrick D WalshSALE Director $445K
6,000 sh × $74.23
Exec Mar 3
Filed Mar 3 · 5:30 PM ET Krista DavisSALE SVP, CHIEF HR OFFICER $296K
3,814 sh across 2 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET Christopher MutzSALE HEAD OF RARE DISEASE $415K
5,323 sh × $78.02
Exec Feb 20
Filed Feb 23 · 5:30 PM ET Christopher MutzSALE HEAD OF RARE DISEASE $538K
7,032 sh × $76.55
Exec Feb 12
Filed Feb 17 · 5:30 PM ET